Analytical Data
-
基因名
YARS2
- Application
-
别名
YARS2；Tyrosine--tRNA ligase. mitochondrial
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y2Z4
-
表达区间
17-477aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MTLNLSVLLP LGLRKAHSGA QGLLAAQKAR GLFKDFFPET GTKIELPELF DRGTASFPQT IYCGFDPTAD SLHVGHLLAL LGLFHLQRAG HNVIALVGGA TARLGDPSGR TKEREALETE RVRANARALR LGLEALAANH QQLFTDGRSW GSFTVLDNSA WYQKQHLVDF LAAVGGHFRM GTLLSRQSVQ LRLKSPEGMS LAEFFYQVLQ AYDFYYLFQR YGCRVQLGGS DQLGNIMSGY EFINKLTGED VFGITVPLIT STTGAKLGKS AGNAVWLNRD KTSPFELYQF FVRQPDDSVE RYLKLFTFLP LPEIDHIMQL HVKEPERRGP QKRLAAEVTK LVHGREGLDS AKRCTQALYH SSIDALEVMS DQELKELFKE APFSEFFLDP GTSVLDTCRK ANAIPDGPRG YRMITEGGVS INHQQVTNPE SVLIVGQHIL KNGLSLLKIG KRNFYIIKWL QL
-
分子量
54 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
YARS2, or mitochondrial tyrosyl-tRNA synthetase 2, is a critical enzyme involved in the mitochondrial translation process, specifically in the charging of tyrosine to its corresponding tRNA. Mutations in the YARS2 gene have been linked to various mitochondrial disorders, including nonsyndromic deafness and other mitochondrial pathologies. Research has increasingly focused on understanding the structure and function of YARS2, as well as its role in mitochondrial biogenesis and metabolism. Given that mitochondrial dysfunction is associated with numerous diseases, including neurodegenerative disorders and aging, elucidating the mechanisms by which YARS2 operates could provide valuable insights into therapeutic strategies. Studies often involve the characterization of the recombinant form of YARS2 to examine its enzymatic activity, interactions with mitochondrial components, and potential post-translational modifications. By investigating the biochemical properties and biological significance of YARS2, researchers aim to uncover the complexities of mitochondrial protein synthesis and the pathological consequences of its dysfunction, thus contributing to the broader field of mitochondrial genetics and disease research.
